Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Gurney, Howard (Primary Chief Investigator)
- Chapman, Nicola, (Research Coordinator)
- Butala, Radhika, (Research Coordinator)
Project: Other